**Core Concept:** Parvovirus B19 is a small, non-enveloped DNA virus that primarily targets erythroid progenitor cells, leading to aplastic crisis in immunocompromised individuals. It is responsible for a variety of clinical manifestations, including erythema infectiosum (fifth disease) in children and chronic arthritis in adults. The virus is transmitted via respiratory droplets, blood, and other bodily fluids.

**Why the Correct Answer is Right:** Parvovirus B19 does not cause significant neuronal or glial infections due to the virus's inability to infect these cells directly. The primary target of the virus is erythroid progenitor cells, leading to anemia and subsequent symptoms in affected individuals.

**Why Each Wrong Option is Incorrect:**

A. **Neuronal infections:** Parvovirus B19 does not cause significant neuronal or glial infections. While it can cause encephalitis in rare cases, these instances are not primary neuronal or glial infections.

B. **Hepatic involvement:** Although the virus can infect hepatocytes, the correct answer states that it does not cause significant hepatic symptoms or diseases.

C. **Pulmonary infections:** While parvovirus B19 can cause transient respiratory symptoms, the focus of the correct answer is on the virus's primary effects on erythroid progenitor cells and anemia, rather than pulmonary manifestations.

D. **Nephrogenic systemic fibrosis (NSF):** Parvovirus B19 does not cause nephrogenic systemic fibrosis, which is a rare complication related to renal fibrosis.

**Clinical Pearl:** Parvovirus B19 infections are usually self-limiting and resolve without specific treatment. However, in immunocompromised individuals, the severity of anemia can lead to aplastic crisis, which requires prompt management.